APLM (Apollomics Corp) Earnings per share growth rate in current year
Apollomics, Inc. (APLM) focus on regulatory drug approval amid fierce competition has triggered a spike in the YoY earnings per share growth rate, which currently stands at 0.00. This chart confirms the success of the targeted therapy strategy for the US and Chinese markets. The development of personalized treatment protocols for lung and liver cancer ensures the company's long-term sustainability.
Analytical breakdowns and data insights for company apollomicsinc.com (APLM)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
- earnings and market multiples details:
APLM - Net Profit|Company Profit Forecast Apollomics, Inc.|APLM - P/E Multiple|Projected Price to Earnings Apollomics|APLM - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Apollomics, Inc.|APLM - Operating profit before deduction of amortization|Earnings per share for the trailing year Apollomics|APLM - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months apollomicsinc.com|APLM - Earnings per share growth in current year|Projected earnings per share growth rate for next year Apollomics, Inc.
Basic company analysis:Apollomics Corp, APLM
This metric reflects the year-over-year dynamics of earnings per share. Comparing the annual EPS growth allows for an assessment of cash flow generation efficiency and capital density. The metric is sensitive to debt load, which is critical for analyzing the issuer's liquidity. For Apollomics, Inc. (APLM), this indicator demonstrates financial stability during the commercialization of oncology drugs. EPS growth will confirm the success of the expansion of targeted therapies in the US and Asian markets.
Main competitors
BeiGene Ltd. - Earnings per share increase in current year|HALO (Halozyme Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Revolution Medicines Corp RVMD|Earnings growth in current year AAPG|Earnings growth in current year cgoncology.com (CGON)|Earnings per share growth in current year UroGen Pharma URGN|BCAX (Bicara Therapeutics Inc) - Earnings per share trend in current year|PSNL - Earnings per share growth in current year|Earnings per share growth rate in current year Erasca Oncology|Delcath Systems, Inc. (DCTH) - Earnings per share growth in current year|YMAB (ymabs.com) - Earnings per share growth in current year|Earnings per share growth in current year Aura Biosciences|Earnings per share growth in current year CADL|Earnings per share growth in current year Accuray Inc. (ARAY)|SLS - Earnings per share growth rate in current year|Earnings per share growth in current year Actuate Therapeutics, Inc. ACTU|CTOR - Net earnings per share growth this year|TuHURA - Earnings growth in current year|Expected net earnings per share growth this year Protara Therapeutics Inc TARA|FATE: Earnings growth in current year|Net earnings per share growth this year Aadi Bioscience|Earnings per share growth in current year TScan Therapeutics Inc|Champions Oncology Corp (CSBR) - Expected net earnings per share growth this year|Net earnings per share growth this year XBIT (XBiotech Inc.)|CVM (cel-sci.com) - Earnings per share increase in current year|Earnings growth in current year OSTX (OS Therapies Inc)|Expected net earnings per share growth this year radiopharmtheranostics.com (RADX)|ARTV - Earnings per share growth in current year|ANL (Adlai Nortye Ltd.) - Earnings per share growth this year|VERU: Earnings growth in current year|Net earnings per share growth this year Tempest Therapeutics Inc|Net earnings per share growth this year XLO|Enochian BioSciences (RENB) - Expected net earnings per share growth this year|Earnings growth in current year MURA|Earnings growth in current year kairospharma.com (KAPA)|Earnings per share growth in current year OnKure Therapeutics OKUR|GDTC (CytoMed Therapeutics Ltd) - Earnings per share trend in current year|CRIS - Earnings per share growth in current year|THAR: Earnings per share growth in current year|advanbiomed.com (ADVB) - Earnings per share growth in current year|Net earnings per share growth this year genprex.com|CLDI (Calidi Biotherapeutics Inc.) - Earnings growth in current year|Net earnings per share growth this year sunshinebiopharma.com (SBFM)|Earnings growth in current year XBIO|Earnings growth in current year Salarius Pharma (SLRX)|Earnings per share growth in current year Purple Biotech PPBT|AONC: Earnings per share growth this year|BeiGene - Earnings growth in current year|Checkpoint Therapeutics Inc. (CKPT) - Net earnings per share growth this year|ELEV: Earnings growth in current year|Earnings per share growth rate in current year iCAD (ICAD)|Earnings per share growth in current year Ikena Oncology Inc.|NTBL: Earnings per share increase in current year|Net earnings per share growth this year VIRX (Viracta Therapeutics)|MOR (MorphoSys Inc) - Earnings per share increase in current year|Earnings growth in current year NAYA (NAYA Bio)|AAPGV - Net earnings per share growth this year
